Pleural mesothelioma is a rare and aggressive cancer. The cancer with a poor prognosis is mainly caused by asbestos. Surgery is an important part of treating pleural mesothelioma, but the impact of surgery on patients’ survival is unclear and sparking debate. A recent study was presented at the World Conference[…]
Overall Survival
Opdivo and Yervoy Before and After Surgery and a New Blood Test are Improving Mesothelioma Treatment
Researchers are reporting promising results for people with mesothelioma who can have surgery. One researcher tested immunotherapy before and after surgery while the other researcher studied a blood test that helps doctors detect mesothelioma earlier than scans. Doctors at several cancer centers, including Johns Hopkins, ran an early clinical trial[…]
Cell Mutations and Peritoneal Mesothelioma
Peritoneal mesothelioma is a hard cancer to treat because it is very aggressive and rare. It is usually found late due to it being rare and having unclear symptoms, making treatment very difficult. Current treatments that can include surgery and chemotherapy have limited success against the cancer. New ways to[…]
New Biomarkers for Diagnosing Mesothelioma
Mesothelioma is a rare cancer linked to asbestos exposure that is dangerous for elderly Americans. It is hard to tell the difference between reactive and cancerous cells. This could be changed though due to a study in the American Journal of Pathology. The study identifies a key biomarker, ACADL, using[…]
Advances in Immunotherapy for Mesothelioma
Malignant mesothelioma is a very rare cancer that often has a poor outlook in cancer treatment. Immunotherapy, especially in the form of immune checkpoint inhibitors, has brought hope. It shows the potential for better outcomes in mesothelioma patients. A new article in Open Respiratory Archives provides a history of recent[…]
Carcinogenicity of Forsterite Compared to Asbestos
Mesothelioma, a rare cancer caused by asbestos, continues to be a global health issue. The most common form of asbestos is chrysotile. Recent research looked at chrysotile and a heat-treated form called forsterite. This research can help with safer asbestos disposal in the future. A recent study examined whether forsterite,[…]
Immunotherapy Benefits and Drawbacks for Treating Mesothelioma
Mesothelioma is a rare and aggressive cancer that creates multiple challenges for patients and caregivers. Immune checkpoint inhibitors have recently shown promise to bring hope to people suffering from this devastating cancer. New data from Australia, however, is questioning their effectiveness and safety. Patients and caregivers must understand immunotherapy and[…]
Importance of Early Detection of Mesothelioma
Malignant mesothelioma is an aggressive cancer mainly caused by asbestos exposure. It mainly affects the pleura, which is the lining of the lungs, but it can also affect the peritoneum, which is the lining of the abdomen. It is very tough for doctors to diagnose, leading to underdiagnosis. A recent[…]
Multimodal Therapy to Treat Pleural Mesothelioma
Malignant pleural mesothelioma is a deadly cancer that is mainly caused by asbestos exposure. It affects the lungs’ lining. It is a very hard to treat cancer because it is very aggressive and is often diagnosed at a late stage. New surgical and therapeutic methods are offering hope though. A[…]
CRS and HIPEC for Peritoneal Mesothelioma
Peritoneal mesothelioma is a rare and aggressive cancer linked to asbestos exposure. A promising option for treating the cancer includes cytoreductive surgery (CRS) with heated chemotherapy (HIPEC). A new article explains cytoreductive surgery and HIPEC for the treatment of peritoneal mesothelioma. Cytoreductive surgery removes as many tumors as possible. In[…]
